Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical CompanyGlobeNewsWire • 08/25/21
Codexis, Inc. (CDXS) CEO John Nicols on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/07/21
Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage IngredientGlobeNewsWire • 08/02/21
Codexis Announces Completion of CodeEvolver® License Technology Transfer with Global Pharmaceutical LeaderGlobeNewsWire • 07/14/21
Strength Seen in Codexis (CDXS): Can Its 12.6% Jump Turn into More Strength?Zacks Investment Research • 06/21/21
Codexis Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme ProductGlobeNewsWire • 06/17/21
Codexis and Takeda Expand Strategic Collaboration and License Agreement to Discover Additional Gene Therapy for a Fourth Rare Genetic DisorderGlobeNewsWire • 06/10/21
Codexis, Inc. (CDXS) CEO John Nicols on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21
AstraZeneca, Bumble, McDonald's, Microsoft and More Monday Afternoon Analyst Calls24/7 Wall Street • 04/12/21
Codexis, Inc.'s (CDXS) CEO John Nicols on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/28/21
Codexis Announces Expansion to New Facility to Accommodate Next Stage of GrowthGlobeNewsWire • 02/09/21
Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose ProductionGlobeNewsWire • 01/13/21